PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $987,000 | +53.3% | 20,080 | 0.0% | 0.11% | +45.9% |
| Q2 2018 | $644,000 | -8.8% | 20,080 | -11.3% | 0.07% | -3.9% |
| Q1 2018 | $706,000 | -2.5% | 22,650 | +42.7% | 0.08% | +14.9% |
| Q4 2017 | $724,000 | +59.1% | 15,870 | +30.9% | 0.07% | +71.8% |
| Q3 2017 | $455,000 | -4.8% | 12,120 | +21.0% | 0.04% | -7.1% |
| Q2 2017 | $478,000 | +32.8% | 10,020 | +26.8% | 0.04% | +31.2% |
| Q1 2017 | $360,000 | +41.2% | 7,900 | 0.0% | 0.03% | +45.5% |
| Q4 2016 | $255,000 | -0.8% | 7,900 | +5.3% | 0.02% | 0.0% |
| Q3 2016 | $257,000 | +21.8% | 7,500 | +172.7% | 0.02% | +29.4% |
| Q4 2015 | $211,000 | – | 2,750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |